|
||
“On day one of the Trump Administration, we will ask Congress to immediately deliver a full repeal of Obamacare. However, it is not enough to simply repeal this terrible legislation. We will work with Congress to make sure we have a series of reforms ready for implementation that follow free market . . . → Read More: Trumping the Affordable Care Act 
“Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer,” Mary Chris Jaklevic, Health News Review. Genetic testing for breast and ovarian cancer risk is cheaper and easier than ever. But just because a test is available doesn’t mean everyone should get it. That message didn’t come through in a recent series of . . . → Read More: Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer PAGES: 1 2 3 Is Childlessness Really Another Side Effect of Cancer? The emphasis on biological motherhood in the field of oncofertility masks at least two societal forces contributing to the cancer/infertility equation. First, the conditions in which people live and work are are already linked to cancers and adverse effects on women’s . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice – 3 PAGES: 1 2 3 Rethinking Normative Expectations As professionals, we have to balance our responsibility to care, inform and research for safer fertility treatments while respecting women’s choices that may at times go against dominant models of womanhood. In doing so, it is crucial to acknowledge several problems stemming from norms about reproduction . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice – 2 PAGES: 1 2 3 Cancer and cancer treatments can have a huge impact on women’s sexual and reproductive health. Yet, when I started my research on breast cancer and social inequality in Spain a decade ago this issue was hardly being addressed in international scholarly debates or in clinical settings. Several of the . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice 
By Kathlyn Stone This post appeared originally on Health News Review (HNR). HNR evaluates health care journalism, advertising, marketing, public relations and other messages that may influence consumers and provides criteria that consumers can use to evaluate these messages themselves. Improving the quality and flow of health care news and information to consumers can be . . . → Read More: Breast cancer-detecting bra won’t go away–and the news coverage is still sub-par
“Breast cancer patients share DNA data,” The Boston Globe, Oct. 28, 2015. Accessing an untapped data source — the DNA of metastatic patients. The Metastatic Breast Cancer Project — a collaboration of the Broad, the Dana-Farber Cancer Institute, and Harvard Medical School, launched this month, asks individuals who have been diagnosed with metastatic breast . . . → Read More: Breast cancer patients share DNA data
In May 2015, the “21st Century Cures Act” was introduced in the U.S. House of Representatives with the goal of promoting the development and speeding the approval of new drugs and devices. Championed by the pharmaceutical, biotechnology, and device industries, some of its provisions could have a significant impact on clinical trial design, what is . . . → Read More: The 21st Century Cures Act 
Originally published at Feminist Reflections on The Society Pages. Graphic arts engage readers in a way text cannot. Told with sequences of pictures, along with narration and dialogue (often in the form of speech bubbles), graphic arts have become increasingly popular media for education and communication as well as social commentary. From disaster preparedness to . . . → Read More: Visualizing Social Change: The Power of Graphic Arts 
In March 2010, French company Poly Implant Prothèse (PIP), a manufacturer of silicone breast implants since 1991 and one of the main producers of silicone breast implants for Europe and Latin America, was implicated in a scandal over a high rate of implant ruptures and use of substandard silicone. PIP had been using industrial-grade silicone . . . → Read More: Murky Devices: The PIP Breast Implant Scandal |
||
| Copyright © 2021 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||